Antony Raharja

Dr. Antony Raharja

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2020 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
ARAntony Raharja
Antony Raharja
ATAlice Tamara
Alice Tamara
LKLi Teng Kok
Li Teng Kok

29 October 2024 in American Journal of Ophthalmology
Verified
Journal Article
Open access
RARodrigo Anguita
Rodrigo Anguita
LDLorenzo Ferro Desideri
Lorenzo Ferro Desideri
PSPhilipp Schwember
Philipp Schwember
NSNeil Shah
Neil Shah
SASyed Ahmed
Syed Ahmed
LWLouisa Wickham
Louisa Wickham
To compare the clinical outcomes of early pars plana vitrectomy (PPV) versus delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). Retrospective, comparative, interventional study. Consecutive patients with type 1 or II diabetes diagnosed with new onset VH secondary to PDR who underwent PPV at Moorfields Eye Hospital between December 2014 and December 2016. Exclusions were prior vitrectomy, iris neovascularization, neovascular glaucoma, macular edema, or presence of tractional/rhegmatogenous retinal detachment. Patients were divided into two groups based on the timing of their surgery: early PPV (≤6 weeks) and delayed PPV (>6 weeks). Demographic and clinical features, including best-corrected visual acuity (BCVA), expressed in logMAR at baseline and 12 months were collected. Statistical analyses, including propensity score matching, were performed using Python 3.10, Scikit-learn, Pandas, and GraphPad Prism 10. BCVA at 12 months postoperatively, reoperation rates, and severity of complications. A total of 178 eyes were analyzed (48 early PPV, 130 delayed PPV). The mean (SD) number of weeks before surgery was 3.36 (SD 1.6) for the early PPV group and 22.56 (SD 17.23) for the delayed PPV group (P < .0001). Baseline BCVA prior to PPV was similar between groups (P = .08). At 12 months, the early PPV group had significantly better BCVA (0.40 logMAR vs 0.67 logMAR; P = .02). Patients without evidence of posterior vitreous detachment on ultrasound or OCT showed more pronounced differences (0.3 logMAR vs 0.7 logMAR; P = .001). The early PPV group had fewer sight-threatening complications (P = .005). Multivariable logistic regression identified initial BCVA, early PPV, and absence of preoperative panretinal photocoagulation as significant predictors of better visual outcomes. Early PPV significantly improves visual outcomes and reduces severe complications in patients with VH secondary to PDR. These findings support the benefits of early surgical intervention to enhance long-term visual prognosis in these patients. However, a randomized clinical trial is warranted.

18 March 2022 in Clinical Medicine
Verified
Journal Article
Open access
PDF file
ARAntony Raharja
Antony Raharja
LWLaurence Whitefield
Laurence Whitefield
Visual loss describes temporary or permanent reduction in visual acuity and/or field. Its aetiology is diverse due to the contributions of the different neuro-ophthalmic structures (eye, optic nerve, and brain) to image formation and perception, but may be categorised into ocular causes (corneal, lenticular, vitreoretinal and macular) or optic neuropathies. Clinical evaluation of visual loss relies on thorough history and examination to guide further tests. In this article, we provide a practical overview of visual loss assessment for general physicians.

1 August 2020 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
VMValentina Mangiafico
Valentina Mangiafico
BSBunny Saberwal
Bunny Saberwal
CLCarlo Lavalle
Carlo Lavalle
ARAntony Raharja
Antony Raharja
ZAZuhair Ahmed
Zuhair Ahmed
SASyed Ahsan
Syed Ahsan

2 May 2022 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
ARAntony Raharja
Antony Raharja
JNJames E. Neffendorf
James E. Neffendorf
TWTom H. Williamson
Tom H. Williamson
To present a case of inadvertent retinal toxicity induced by a standard dose of subconjunctival cefuroxime after epiretinal membrane surgery. Narrative review of cefuroxime overdose or toxicity after intraocular surgery was carried out to describe characteristics of cefuroxime toxicity and their relationship to visual outcome. A 64-year-old man underwent pars plana vitrectomy (PPV) with epiretinal membrane peel and received a standard dose of subconjunctival cefuroxime as endophthalmitis prophylaxis. At two weeks, visual acuity measured counting fingers, and fundus examination showed haemorrhages and cotton wool spots. Fluorescein angiography confirmed widespread ischaemia involving the macula. Subsequent litigation ruled that inadvertent cefuroxime toxicity after an accidental penetration of sclera was the likely aetiology. In addition to inadvertent overdose due to dilution errors, accidental scleral penetration is another mechanism for drug toxicity following subconjunctival cefuroxime injection. Literature review revealed broadly different manifestations of cefuroxime retinal toxicity. This case highlights the need to consider severe cefuroxime toxicity in patients presenting with unexplained post-PPV visual loss.

3 July 2023 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
ARAntony Raharja
Antony Raharja
WMWessam Mina
Wessam Mina
ZAZahra Ashena
Zahra Ashena
To present a case of irreversible corneal edema after 10 years of amantadine use. A literature review was carried out to describe the clinical characteristics and outcomes of amantadine-induced corneal edema. A 36-year-old woman presented with a 6-week history of gradually progressive bilateral painless visual loss with visual acuity (VA) of 20/350 and 20/300 in the right and left eye, respectively. Examination showed bilateral diffuse central corneal edema with multiple Descemet membrane folds without endothelial guttata, keratic precipitates or intraocular inflammation. This did not respond to hypertonic saline drops and empirical treatment for presumed herpetic endotheliitis with oral acyclovir. Medication review revealed the use of amantadine 100mg daily for the past 10 years, prescribed by her neurologist for fatigue. Despite discontinuing amantadine, corneal edema was irreversible due to a markedly reduced endothelial cell count of 625 (right) and 680 cells/mm2 (left). This case highlights the need to consider amantadine as a cause of unexplained bilateral non-guttae corneal edema. A literature review of 33 case reports revealed broadly similar features of amantadine-induced corneal edema; whilst most cases had favorable outcomes with median VA 20/25 (interquartile range IQR 20/20–20/30) and complete resolution of corneal edema within 30 days (IQR 14–35) of amantadine discontinuation, most experienced low endothelial cell density 759 cells/mm2 (IQR 621–1078). Taken together, screening specular microscopy ought to be considered for those in whom amantadine is likely required long-term.